The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant nivolumab plus concurrent chemoradiation in stage II/III esophageal/gastroesophageal junction cancer.
 
Ronan Joseph Kelly
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Cardinal Health; Clovis Oncology; EMD Serono; Gritstone Bio; Lilly; Novartis; OncoMed
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Kellie Nicole Smith
No Relationships to Disclose
 
Valsamo Anagnostou
No Relationships to Disclose
 
Elizabeth Thompson
No Relationships to Disclose
 
Russell K. Hales
No Relationships to Disclose
 
Richard J. James Battafarano
No Relationships to Disclose
 
K Ranh Voong
No Relationships to Disclose
 
Stephen C. Yang
No Relationships to Disclose
 
Josephine Louella Feliciano
Consulting or Advisory Role - AstraZeneca; Genentech; Merck; Pfizer
Research Funding - genentech; Merck
 
Eun Ji Shin
Consulting or Advisory Role - Boston Scientific; C2 Therapeutics; Medtronic
 
Chen Hu
No Relationships to Disclose
 
Margueritta El Asmar
No Relationships to Disclose
 
Hok Yee Chan
No Relationships to Disclose
 
Victor E. Velculescu
Leadership - Personal Genome Diagnostics
Stock and Other Ownership Interests - Ignyta; Personal Genome Diagnostics
Consulting or Advisory Role - Ignyta; Janssen Diagnostics; Personal Genome Diagnostics; Quintiles
Patents, Royalties, Other Intellectual Property - Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Genzyme.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Myriad.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Personal Genome Diagnostics.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Qiagen.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Roche.
 
Cynthia Sears
Travel, Accommodations, Expenses - AbbVie
 
Drew M. Pardoll
Stock and Other Ownership Interests - Aduro Biotech; Compugen; Jounce Therapeutics; Neximmune; Potenza Therapeutics
Consulting or Advisory Role - Amgen; Medimmune; Merck; Pfizer; Sanofi
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Compugen; Potenza Therapeutics
Patents, Royalties, Other Intellectual Property - Royalties on patents licensed to Aduro, BMS, Potenza
 
Ali Imran Amjad
No Relationships to Disclose
 
Patrizia Guerrieri
No Relationships to Disclose
 
Blair Anderson Jobe
No Relationships to Disclose
 
Ali Hussainy Zaidi
No Relationships to Disclose